ASTA Contends Risk Profile Overstates Risk of Spices
ASTA submitted extensive comments and a scientific review of the FDA’s Draft Risk Profile on Pathogens and Filth in Spices. These comments will now be reviewed by FDA and considered as the risk profile is finalized.
If you have media inquiries or require assistance, send us an email
1101 17th Street, NW Suite 700
Washington, DC 20036 USA